ReviewTranslational cancer research2026

Exosomal miRNA as a biomarker for diagnosis and prognosis, and a new target for regulating treatment resistance in DLBCL: a research progress narrative review.

Huifang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.